Lion Point Capital, LP
CIK:0001643354
Hedge Fund
$518M AUM
19 holdings
New York, NY, United States
Lion Point Capital is a global investment firm that seeks to invest in equity and debt securities of undervalued public and private companies, employing a value-oriented investment philosophy to activist opportunities across the capital structure.
Investment Strategy
Global special situations with a focus on value-oriented investment and activist opportunities
Top Buys
M
MISTMILESTONE PHARMACEUTICALS IN+$625.6K
F
FENCFENNEC PHARMACEUTICALS INC+$432.5K
K
KNSAKINIKSA PHARMACEUTICALS INTL+$250.6K
B
BBIOBRIDGEBIO PHARMA INC+$223.9K
M
MCRBSERES THERAPEUTICS INC+$189.3K
Top Sells
I
INSMINSMED INC-$1.3M
B
BLUEBLUEBIRD BIO INC-$385.1K
A
ARDXARDELYX INC-$332.0K
M
MCRBSERES THERAPEUTICS INC-$238.5K
B
BHVNBIOHAVEN LTD-$225.4K
Top Holdings
F
FENCFENNEC PHARMACEUTICALS INC+11.0%$1.6M
A
ARDXARDELYX INC+8.9%$1.3M
K
KNSAKINIKSA PHARMACEUTICALS INTL+8.6%$1.3M
B
BBIOBRIDGEBIO PHARMA INC+7.6%$1.1M
I
INSMINSMED INC+7.3%$1.1M
Equity Positions (19)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
F FENC | FENNEC PHARMACEUTICALS INC | 11.03% | $1.6M | 195,700 | $8.59 | $8.30 | +$432.5K |
A ARDX | ARDELYX INC | 8.93% | $1.3M | 335,400 | $2.55 | $3.92 | -$332.0K |
K KNSA | KINIKSA PHARMACEUTICALS INTL | 8.62% | $1.3M | 45,900 | $18.00 | $27.67 | +$250.6K |
B BBIO | BRIDGEBIO PHARMA INC | 7.62% | $1.1M | 26,000 | $25.20 | $43.18 | +$223.9K |
I INSM | INSMED INC | 7.28% | $1.1M | 10,650 | $21.29 | $100.64 | -$1.3M |
Industry Allocation
PHARMACEUTICAL PREPARATIONS
+81.2%
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
+21.0%
BLANK CHECKS
+3.8%